Study 2: tacrolimus as secondary intervention versus continuation of cyclosporine in patients at risk for chronic renal allograft failure results in improved renal function, decreased cardiovascular risk, and no increased risk for diabetes
Thomas H. WaidVolume:
17
Year:
2003
Language:
english
DOI:
10.1016/j.trre.2003.10.016
File:
PDF, 38 KB
english, 2003